A large body of data demonstrates that interferon regulatory factor 5 (IRF5) and nuclear factor kappa B (NF-jB) are the two major transcription factors in classically activated macrophages responsible for the transcriptional control of proinflammatory genes. Although recent evidence suggests that IRF5 interacts with certain members of the nuclear factor kappa B pathway, the extent of cooperation and its implications in disease are ambiguous. Since both pathways are known for their strong contributions in TLR8 signaling we used the human monocytic cell line THP-1.Dual, featuring gene reporters for NF-jB and IRFs, to simultaneously study the roles of IRF5 and the NFjB subunit p65 in TLR8-mediated gene reporter activities. Furthermore, we profiled from these cells the proinflammatory cytokines involved in the differentiation of TH1 and TH17 cells. After ablation of IRF5 and/or p65 we activated the resultant cells with the TLR8 agonists R848 or the psoriasisassociated antimicrobial peptide LL-37 complexed with ssRNA and demonstrate that IRF5 deficiency drastically impairs the secretion of IL-1b, IL-6, IL-12, IL-23 and TNFa. In contrast, the lack of p65 impaired only IL-6, IL-12, and IL-23 secretion. Furthermore, we discovered that upon TLR8 stimulation, IRF5 but not NF-jB signaling is essential to provide a cytokine milieu supporting TH1 responses. Additionally, we demonstrate that IRF5 and NF-jB cooperate to provide a cytokine milieu supporting TH17 responses. Therefore, the distinct role of IRF5 in the intricate signaling network downstream of TLR8 may open new treatment options interfering with but not disrupting NF-jB signaling in human diseases.
A large body of data demonstrates that interferon regulatory factor 5 (IRF5) and nuclear factor kappa B (NF-jB) are the two major transcription factors in classically activated macrophages responsible for the transcriptional control of proinflammatory genes. Although recent evidence suggests that IRF5 interacts with certain members of the nuclear factor kappa B pathway, the extent of cooperation and its implications in disease are ambiguous. Since both pathways are known for their strong contributions in TLR8 signaling we used the human monocytic cell line THP-1.Dual, featuring gene reporters for NF-jB and IRFs, to simultaneously study the roles of IRF5 and the NFjB subunit p65 in TLR8-mediated gene reporter activities. Furthermore, we profiled from these cells the proinflammatory cytokines involved in the differentiation of TH1 and TH17 cells. After ablation of IRF5 and/or p65 we activated the resultant cells with the TLR8 agonists R848 or the psoriasisassociated antimicrobial peptide LL-37 complexed with ssRNA and demonstrate that IRF5 deficiency drastically impairs the secretion of IL-1b, IL-6, IL-12, IL-23 and TNFa. In contrast, the lack of p65 impaired only IL-6, IL-12, and IL-23 secretion. Furthermore, we discovered that upon TLR8 stimulation, IRF5 but not NF-jB signaling is essential to provide a cytokine milieu supporting TH1 responses. Additionally, we demonstrate that IRF5 and NF-jB cooperate to provide a cytokine milieu supporting TH17 responses. Therefore, the distinct role of IRF5 in the intricate signaling network downstream of TLR8 may open new treatment options interfering with but not disrupting NF-jB signaling in human diseases.
Introduction
The interferon regulatory factor (IRF) and nuclear factor kappa B (NF-jB) transcription factor families are major players of the innate immune system. Both families are key targets downstream of pattern recognition receptors such as toll like receptors (TLR) and together orchestrate many autoimmune and inflammatory responses as well as host defenses to various pathogens [1] .
The mammalian family of IRF transcription factors consists of nine members (IRF1-9) and is recognized as a crucial player in the regulation of immune responses, immune cell development and the pathogenesis of multiple immune associated diseases [2] . IRF5 plays an integral role in the gene induction of inflammatory factors and is critical for the production of pro-inflammatory cytokines [3] . Additionally, IRF5 possesses a key role in polarizing macrophages towards a pro-inflammatory M1 like phenotype and is consequently, due to its impact on the phenotype of antigen presenting cells (APC), involved in the promotion of TH1 and TH17 responses [4, 5] . In humans, IRF5 has been associated with various autoimmune diseases such as systemic and cutaneous lupus erythematosus [6, 7] , Sj€ ogren syndrome [8] , rheumatoid arthritis [9, 10] , ulcerative colitis, and Crohn's disease [11, 12] , multiple sclerosis [13] as well as systemic sclerosis [14] .
The classical NF-jB pathway also embodies an indispensable signal cascade involved in a broad range of biological processes, including immune responses, cell survival, stress responses, and maturation of various cell types. It consists of five Rel proteins, namely p50, p52, RelA (p65), RelB, and c-Rel [15] , and is activated by a larger number of extracellular signals transduced by surface receptors such as the IL-1 and TNF receptor families, the B-and T cell receptors and the TLRs [16] . The p65 subunit is a critical effector of the canonical pathway controlling the induction of proinflammatory cytokines in macrophages and dendritic cells (DC) which subsequently shape the permissive microenvironment for the differentiation of autoimmune TH1 and TH17 cell responses. Dysregulated NF-jB activity is often observed in chronic autoimmune disorders and has been implicated in the pathogenesis of a number of autoimmune diseases such as rheumatoid arthritis [17] , systemic lupus erythematosus [18] , type I diabetes [17] , multiple sclerosis [19] , inflammatory bowel disease [20] and psoriasis vulgaris [21] .
Thus, both IRF5 and NF-jB are critical in the regulation of pro-inflammatory responses and promote the differentiation of TH1 and TH17 in health and disease. Despite strong genetic evidence for overlapping proinflammatory target genes, the kinase(s) responsible for the phosphorylation of IRF5 remained elusive for many years. Two recent articles disclosed the unexpected finding that a core element of the classical NF-jB cascade, the kinase IKKb, phosphorylates IRF5 [22, 23] and suggested a so far unknown crosstalk between NF-jB and IRF5 to position IKKb as a master regulator of innate immune signaling. Whereas it is now demonstrated that IKKb activates the two transcription factors IRF5 and NF-jB in innate immune cells, it is still ambiguous at which level the two signaling pathways cooperate in the transcriptional control of pro-inflammatory target genes. So far only a few studies have tried to investigate the potential cooperation between IRF5 and NF-jB signaling. Steinhagen et al. disclosed some details of the IRF5 signaling network in the human plasmacytoid DC (pDC) cell line CAL-1. They discovered that IRF5 and NF-jB p50 colocalize in the nucleus of these cells and are key co-regulators of IL-6 and interferon b (IFNb) upon stimulation of the TLR9 pathway [24] . In human DC Krausgruber et al. [25] detected that both IRF5 and p65 can mediate the transcription of TNF mRNA and propose that IRF5 and p65 form a nuclear protein-protein complex to control the secretion of TNFa upon lipopolysaccharide (LPS) stimulation. Another study from the Udalova group demonstrated the presence of a tightly regulated signaling network between both pathways and postulated an IRF5/p65 cistrome controlling the transcription of certain pro-inflammatory genes. They demonstrated in murine bone marrow derived macrophages that upon TLR4 stimulation, the expression of the pro-inflammatory genes IL1a, IL6, IL12a, and TNF was affected by both IRF5 and p65. Surprisingly the knock down (KD) of p65 also impaired the recruitment of IRF5 to these immune related gene loci illustrating the cooperation of both transcription factors [26] .
Toll-like receptor expression in the skin is observed in many cell types such as dermal monocytes and macrophages, DC, T and B lymphocytes, mast cells, endothelial cells, fibroblasts, keratinocytes and adipocytes and has been implicated in cutaneous immune responses against a wide range of skin infections. TLR signaling contributes to the pathophysiology of common skin diseases such as psoriasis vulgaris [27] . Skin infiltrating monocytes as well as resident DC and macrophages are central pathogenic players shaping the microenvironment to provoke TH1 and TH17 responses which are associated with psoriasis [28, 29] . Recent studies demonstrated that LL-37, a cathelicidin antimicrobial peptide, which is found at high levels in psoriatic skin, can convert otherwise nonstimulatory self-RNA and self-DNA released by dying cells into potent activators of TLR7/8 and TLR9 on innate immune cells resulting in production of inflammatory cytokines and aggravation of disease [30, 31] . This may be one important mechanism of how TLRs can promote autoimmunity in psoriatic skin lesions. Therefore, a better understanding of the biology of the TLR signaling network may result in new insights which can help to develop novel treatments for psoriasis and other cutaneous manifestations.
Since the IRF5 as well as the NF-jB pathways are known for their strong contributions in TLR8 signaling [32] we compared in the current study the roles of the two central mediators IRF5 and NF-jB on the control of TLR8-mediated pro-inflammatory cytokines and their subsequent impact on TH1 and TH17 differentiation. We dissected the signaling pathways of both transcription factors in the monocytic cell line THP-1.Dual.Cas9 tg (THP-1 DuCa ), a CRISPR associated protein 9 (Cas9) transgenic cell line with simultaneous NF-jB and ISRE gene reporters, activated with the TLR8 agonists R848 and the pathogenic antimicrobial peptide LL-37 complexed with single strand RNA. We revealed both cooperating but also divergent roles of IRF5 and p65 in the signaling cascade. Whereas IRF5 signaling is important for the expression of IL-1b, TNFa, IL-6, IL-12, and IL-23 and therefore essential for mounting TH1 and TH17 responses, we discovered that TLR8 mediated NF-jB signaling is of lesser importance: p65 had only minor or no effects on TLR8 induced IL-1b and TNFa and TH1 responses, but impacted the secretion of IL-6, IL-12 and IL-23 and subsequently the development or maintenance of TH17 responses. Further advances in the understanding of this important signaling network are necessary to eventually develop more selective drugs for clinical benefit. ). Sequencing of both clones revealed frameshift deletions in exon 2 (29 and 68 bp, respectively, data not shown) resulting in the lack of IRF5 protein in both cell lines (Fig. 1B) Fig. 2A) . While TNFa, IL-6 and IL-23 were induced in a dose dependent manner, no IL-12 was detected in the supernatants of R848 activated na€ ıve THP-1 DuCa cells (data not shown). Interestingly, we observed a complex picture of IRF5 and p65 involvement in the TLR8 signaling pathway. Whereas p65 deficiency resulted in a strong reduction of IL-6 and IL-23, the lack of p65 proved to be negligible for the induction of TNFa. IRF5, however, proved to be essential for the induction of all three cytokines since the levels of IL-6, IL-23, and TNFa levels in the supernatants of R848 (10 and 30 lM) activated THP-1 DuCa .
Results
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To mimic a disease setting and compare the impact of p65 and/or IRF5 in the TLR8 pathway in na€ ıve versus inflamed conditions, we induced a proinflammatory M1-like phenotype in THP-1 DuCa cells by the incubation with recombinant human IFNc for 24 h. Subsequently, we activated the respective IFNc differentiated THP-1 DuCa cells with R848 and measured the secreted cytokines relevant for TH1 and TH17 differentiation after 24 h of culture (Fig. 2B ). Under these conditions we were able to detect in addition to TNFa, IL-6 and IL-23 also IL-12 in the culture supernatants. Similar to the na€ ıve THP-1 DuCa cells, the consequences of the p65 deficiency alone in IFNc differentiated THP-1 DuCa cells appeared to be less dramatic as compared to the cells lacking IRF5. Whereas the impact of p65 on R848 induced TNFa was negligible, the secretion of IL-12, IL-23, and IL-6 were significantly, but only partially impaired. In contrast, IRF5 appeared to be more essential for the induction of TH1 and TH17 inducing cytokines. Whereas IRF5, similar to the p65 deficiency, resulted only in a partial inhibition of IL-6 secretion, the IRF5 KO (Fig. 3A) . Similar to the roles of IRF5 and p65 in the control of TLR8-mediated cytokine release, we observed that both transcription factors took part in the activation of both gene reporters. First of all, we observed that na€ ıve THP-1 DuCa cells were less sensitive to R848 activation than IFNc differentiated THP-1 DuCa cells with the former requiring higher concentrations of R848 to trigger gene reporter activities. Nevertheless, we detected under both conditions a dose dependent induction of the ISRE as well as the NF-jB gene reporters.
The deficiency of IRF5 in na€ ıve and p65 KD THP-1 DuCa cells completely abrogated the ISRE gene reporter activity at all R848 concentrations. In contrast the lack of p65 in the na€ ıve THP-1 DuCa cells only partially inhibited the induction of the ISRE gene reporter. Interestingly, the impact of the p65 deficiency declined with increasing stimulation (Fig. 3A) .
Similarly, in the IFNc differentiated THP-1 DuCa cells, the lack of IRF5 had a stronger impact on the ISRE gene reporter activities than the p65 deficiency. Whereas the IRF5 KO cells showed at all R848 concentrations, a strong reduction of the ISRE gene reporter activity, the impact of p65 deficiency on the ISRE gene reporter activity decreased with increasing R848 concentrations. Additionally we observed that in IFNc differentiated THP-1 DuCa cells only the double deficiency of p65 and IRF5 almost completely abolished the ISRE gene reporter activities suggesting synergy (Fig. 3A) .
Taken together, these data show that in na€ ıve as well as IFNc differentiated THP-1 DuCa cells IRF5 is the prevailing transcription factor for the induction of ISRE regulated genes upon R848 stimulation.
R848 ( KD cells displayed no gene reporter activity at all when compared to the basal control (Fig. 3A) .
Similarly, to the na€ ıve cells we detected also in the IFNc differentiated THP-1 DuCa cells equivalent roles of p65 and IRF5 in the activation of the NF-jB signaling cascade. With 0.1 lM R848 stimulation, the single as well as the double deficient THP-1 DuCa cells entirely abrogated NF-jB activities. We noticed that at 0.3 and 1 lM R848 stimulation, the individual lack of p65 or IRF5 resulted in only a partial inhibition of the NF-jB activity. At the 1 lM R848 stimulation, the double deficient IRF5 KO .p65
KD cells synergistically blocked the NF-jB activity completely (Fig. 3A) .
Interestingly we noted that IRF5 deficiency alone was enough to abolish the ISRE and NF-jB gene reporter activities in na€ ıve THP-1 DuCa cells. In contrast the lack of both transcription factors was needed for the efficient abrogation of ISRE as well as NF-jB signaling in the IFNc differentiated THP-1 DuCa cells (Fig. 3A) .
In agreement with IKKb being an upstream activator of both p65 and IRF5 as shown by others [22, 23, 33] , we performed experiments with specific IKKb inhibitors like AFN700 [34, 35] to confirm NFjB and ISRE signaling as a TLR8 pathway specific read-out. We activated na€ ıve and IFNc differentiated WT THP-1 DuCa cells with R848 at the half maximal effective concentrations of R848 (EC 50 ) calculated from an initial six point dose response curve (data not shown) in the presence of various doses of AFN700 and measured 24 h after activation, the ISRE and NFjB gene reporter activities. As expected AFN700 abolished ISRE and NF-jB signaling in both na€ ıve and IFNc differentiated THP-1 DuCa cells in a dose dependent manner without affecting cell viability (Fig. 3B) . To strengthen the point we validated the experiment with additional two well-established but structurally unrelated IKKb inhibitors like BI605906 [36] and PHA-048 (data not shown) [37] confirming the data generated with AFN700 (Fig. 3C ).
These data demonstrate that in the R848 induced NF-jB signaling cascade in na€ ıve as well as differentiated THP-1 DuCa cells both IRF5 and p65 contribute to the induction of NF-jB regulated genes.
IRF5 has no impact on TNFa induced ISRE and NF-jB gene reporter activities
To investigate whether the observed effects of IRF5 were specific for the TLR8 signaling pathway, we also activated the TNFR pathway with recombinant human TNFa and quantified the ISRE and NF-jB gene reporter activities after 24 h. As anticipated from papers demonstrating that TNFa does not mediate ISRE activation [38] we did not detect any ISRE gene reporter activities in na€ ıve THP-1 DuCa cells upon TNFR signaling, but surprisingly observed in IFNc differentiated THP-1 DuCa cells that TNFa weakly induced the ISRE gene reporter. In contrast, in na€ ıve as well as IFNc differentiated THP-1 DuCa cells, TNFa strongly induced NF-jB gene reporter activity confirming published data [1] . Additionally we confirmed that TNFa induced NF-jB signaling is dependent on p65 signaling as the KD of p65 completely inhibited the gene reporter signal (under all conditions NF-jB inhibition was > 96.2%). The IRF5 KO cells did not show any significant reduction of the NF-jB gene reporter activity (Fig. 4A) .
We subsequently designed experiments to determine the contribution of TNFa signaling on the IKKb pathway. Therefore, we activated na€ ıve and IFNc differentiated WT THP-1 DuCa cells with recombinant human TNFa at the half maximal effective concentrations (EC 50 ) calculated from an initial six point dose response curve (data not shown) in the presence of various doses of AFN700 and measured 24 h later, ISRE and NF-jB gene reporter activities (Fig. 4B) . Additionally we monitored the cell viability with cell titer glow (data not shown). As expected we observed TNFa signaling was dependent on IKKb signaling since the inhibitor dose dependently abrogated the responses of the NF-jB gene reporter. Whereas AFN700 completely abolished TNFa induced NF-jB gene reporter activities in na€ ıve as well as IFNc differentiated THP-1 DuCa cells, we were only able to partially confirm that the weak induction of the ISRE gene reporter in IFNc differentiated THP-1 DuCa cells was IKKb dependent as AFN700 at higher concentrations > 0.3 lM in combination with the TNFa stimulation proved to be toxic (data not shown). To strengthen the point we validated the experiment with two additional well-established but structurally unrelated IKKb inhibitors like BI605906 [36] and PHA-048 (data not shown) [37] confirming the data generated with AFN700 (Fig. 4C) .
These data show that in TNFa stimulated THP- IRF5 activity might be a safe pharmaceutical option to inhibit components of TLR induced NF-jB signaling.
IRF5 is central for the regulation of TH1 and TH17-inducing cytokines in THP-1 DuCa cells activated with the TLR8 agonist and psoriasisassociated antimicrobial peptide LL-37
To investigate the implication of IRF5 in TLR8 mediated pathologies in a more physiological setting, we activated the respective THP-1 DuCa cells with the antimicrobial peptide LL-37 complexed to single strand RNA (ssRNA), a TLR8 agonist observed in psoriatic skin lesions. Self ssRNA/LL-37 complexes are potent activators of TLR7/8 on resident dermal DC and macrophages resulting in stimulation of inflammatory cytokine release [30, 31] Generally we observed with both TLR8 agonists R848 (Fig. 2B) and LL-37/ssRNA (Fig. 5A ) comparable cytokine responses. As seen with R848, TNFa induction with LL-37/ssRNA was almost completely dependent on IRF5, while the KD of p65 had little or no effect. Likewise, the induction of IL-1b was mainly dependent on IRF5. Whereas the KD of p65 resulted in a significant but only weak reduction of IL-1b in the supernatants, IRF5 deficiency strongly inhibited the IL-1b levels by 83.5 AE 5.8%. The double deficient IRF5 KO .p65 KD THP-1 DuCa cells completely blocked the secretion of IL-1b (98.2 AE 0.9%). The levels of LL-37/ssRNA induced IL-6, IL-12 and IL-23 in the culture supernatants were robust and significantly decreased with the lack of one or the other transcription factor.
While IRF5 is superior to p65 for TH1 differentiation, it cooperates with p65 during the induction of TH17 cells Finally, we wanted to compare the importance of the p65 and IRF5 signaling cascades in APC to provide a cytokine milieu for TH1 and TH17 differentiation and therefore collected conditioned media from LL-37/ ssRNA activated WT, p65 KD (Fig. 5B) or supplemented the T cell cultures with conditioned media derived from the respective THP-1 DuCa cells stimulated with LL-37/ssRNA (Fig. 5C ). Although the 6 days cultures with na€ ıve CD4 + T cells aim to examine the differentiation of TH1 and TH17 cells, the 3 days cultures with total CD4 + T cells are likely not sufficient to measure T cell differentiation, but rather reflect the cytokine profiles of activated precommitted effector or memory T cells.
By spiking-in recombinant human IL-1b, IL-6, IL-12, IL-23, and TNFa at the concentrations determined in the supernatants of the either p65 KD KD THP-1 DuCa cells and resulted in a significantly lower production of IL-17A in the supernatants of total CD4 + T cells. The much higher levels of IL-17A observed in the total T cell cultures may also reflect the presence of precommitted effector or memory T cells in the total CD4 + T cells fraction (Fig. 5B) .
Interestingly, in the experiments using conditioned media of the respective THP-1 DuCa cells activated with LL-37/ssRNA, the lack of either IRF5 or p65 revealed distinct roles of both transcription factors in the polarization of TH1 and TH17 cells from total CD4 + T cells. Whereas the lack of p65 was negligible, IRF5 deficiency was enough to completely diminish IFNc in the T cell supernatants. IL-17A levels in the T cell cultures but did not differentiate from each other (Fig. 5C ). These results identify IRF5 as a key transcription factor in THP-1 DuCa cells for the regulation of soluble factors important for TH1/TH17 differentiation and activation of precommitted TH1 cells. Otherwise IRF5 needs to cooperate with p65 to regulate the soluble factors important for TH17 responses of precommitted CD4 + T cells.
Discussion
The immune system is constantly challenged with many different pathogens and conditions and needs to be able to react to different stimuli in an appropriate manner to avoid the development of excessive immune responses that may lead to autoimmune disorders. To put this into effect the immune system has evolved a diverse range of immune cells each with a tightly regulated signaling network. Cells of the innate immune system such as macrophages undergo distinct phenotypical and functional switches in response to environmental signals or chronically inflamed autoimmune conditions and as a consequence shape also the adaptive immune system. Recent findings have highlighted that in addition to the NF-jB pathway, the IRF5 signaling cascade is of major importance for the polarization of macrophages and their production of multiple pro-inflammatory cytokines which subsequently impact the differentiation of TH1 and TH17 cells [5] . Despite the progress that has been made to understand the interplay of both transcription factors, the mechanisms as well as the heterogeneity between pathological pathways and cell types is to a large extent still unknown. Further advances in the understanding of this important signaling network are necessary to eventually develop more selective drugs for clinical benefit. In the current study we investigated the role of TLR8 signaling in APC and examined the impact of TLR8 induced cytokines on the subsequent differentiation of human CD4 + T cells. We present evidence that IRF5 cooperates in the TLR8 pathway with members of the NF-jB signaling cascade to control the secretion of pro-inflammatory cytokines affecting TH1 and TH17 differentiation as well as the activation of precommitted effector or memory TH1 and TH17 cells. In the TLR8 pathway, IRF5 even seems to be superior to NF-jB signaling as the deficiency of IRF5 drastically impaired IL-1b, IL-6, IL-12, IL-23 and TNFa secretion whereas the lack of p65 only impacted IL-6, IL-12 and IL-23 expression. Furthermore, IRF5 seems to be solely responsible for the regulation of soluble factors important for TH1 differentiation as well as the activation of precommitted TH1 CD4 + T cells. Consistent with these in vitro derived data, we observed in a TH1 driven in vivo disease model also a very strong protection in mice deficient of IRF5. In the antigen induced arthritis (AIA) model the knee swelling of the IRF5 KO mice was strongly reduced (73.9 AE 4.5%, data not shown) compared to the WT littermates confirming published data [39] . In contrast, IRF5 and p65 seem to fulfill diverse roles in the differentiation of TH17 or the activation of precommitted TH17 CD4 + T cells. Whereas IRF5 seems to be key for the regulation of soluble factors important for TH17 differentiation, both transcription factors cooperate in the regulation of soluble factors important for activation of precommitted effector or memory TH17 cells. The impact of IRF5 and NF-jB signaling on the regulation of TNFa secretion seems to vary with species, cell type and stimulus. In human TLR4 stimulated monocyte derived DC, p65 and IRF5 cooperate in the induction of TNFa as the KD of one or the other transcription factor only partially diminished TNFa mRNA whereas only the concurrent KD of both p65 and IRF5 significantly impaired the transcription of TNF mRNA [25] . In human pDC IRF5 and the NF-jB member p50 co-regulate the expression of IFNb and IL-6 upon activation with TLR9 agonists [24] . In human macrophages it has been shown that IRF5 controls the expression of IL-1b, IL-6, IL-12, IL-23 and TNFa upon activation with TLR4 agonists [5] . In the murine system the roles of IRF5 and p65 on the secretion of TLR induced pro-inflammatory cytokines is more pronounced. Genetic studies in mice deficient for either IRF5 or particular members of the canonical NF-jB signaling complex reveal IL-1b, IL-6, IL-12, IL-23 and TNFa dependency on one or the other signaling cascade [1, 5] . Interestingly, Takaoka et al. [3] observed that even though the induction of pro-inflammatory cytokines were markedly suppressed in the IRF5 KO mice, NF-jB signaling appeared to be normal in the absence of IRF5. Data from a recent study performed in TLR4 stimulated murine macrophages, suggest that IRF5 and p65 together form a unique IRF5/p65 cistrome to control the targeting of pro-inflammatory cytokines. The authors confirmed by CHIP sequencing the dependency of TLR4 induced IL-1b, IL-6, IL-12, IL-23 and TNFa on the transcriptional activity of both IRF5 and p65 [26] . Whereas in the mouse system there is a large overlap in target genes of both transcription factors, the human TLR signaling cascades downstream of IKKb seem to be more intricate. Although our data shows that the regulation of IL-6, IL-12 and IL-23 is impaired by the lack of either IRF5 or p65 and therefore suggesting the cooperation by both transcription factors, the induction of IL-1b and TNFa was not impaired by the disruption of the NF-jB signaling, pointing towards a solitary role of IRF5.
The signaling cascade downstream of TNFR is different from TLR signaling. Although the toll-like and TNF receptors are structurally diverse, they both use similar signal transduction mechanisms including the activation of IKKb and NF-jB, however, the TNFR induced signaling did not result in the activation of IRF5 confirming observations already made by Ren et al. [23] . IKKb, central to both signaling cascades, seems to differentiate the incoming signals and subsequently guides them into either NF-jB or IRF5. How IKKb streams the incoming signals from TNFR and TLRs allowing the differentiated phosphorylation of downstream targets requires further dissection. Most likely the formation of deviating signaling complexes or different post-translational modifications of IKKb might explain the dissociation into one or the other signaling cascade.
Apart from the direct role of both transcription factors on the control of pro-inflammatory cytokines in TLR8 activated THP-1 DuCa cells, we wanted to investigate the implication of the cytokine profiles of the respective THP-1 DuCa cells deficient of IRF5 and/or p65 on the activation or differentiation of TH1 and TH17 cells. Whereas we demonstrate that IRF5 is the key transcription factor expressed in antigen presenting cells to provide the right cytokine environment upon TLR8 stimulation for TH1/TH17 differentiation from na€ ıve CD4 + T cells and the activation of precommitted TH1 cells, it appears that NF-jB and IRF5 need to collaborate for TH17 responses of precommitted CD4 + T cells. These data highlight the importance of IRF5 on the induction of TH1 and TH17 cells and confirms published murine data in the human system. Two recent publications have shown in IRF5 KO mice that the lack of IRF5 impairs the generation of TH1 as well as TH17 cells. Weiss et al. have shown that in the AIA arthritis model, IRF5 KO mice have less TH1 and TH17 CD4 + T cells in the joints, and this led to protection of arthritis development in the KO mice. Further, Krausgruber et al. demonstrated that upon intraperitoneal LPS injection, IRF5 deficient mice elicit less TH1 and TH17 cell infiltration into the peritoneal cavity. Furthermore it is interesting to see that the effects of IRF5 on the generation of TH1 cells were always stronger than those observed during the generation of TH17 cells [5, 39] . These findings support that additional transcription factors such as p65 are important during TH17 responses. Despite the lack of IL-12 in the supernatants of the THP-1
DuCa cells lacking p65, we were surprised to see that the CD4 + T cell cultures supplemented with the respective human recombinant cytokines or conditioned media derived from p65 KD THP-1 DuCa cells still mounted significant TH1 responses. This might be due to either secondary effects of TNFa and IL-1b or primary effects of other undetermined cytokines in the conditioned media resembling other members of the IL-1 or IL-12 family such as IL-18 or IL-27. Both have been shown to support the expansion or induction of TH1 responses [40] [41] [42] .
Because of the central role and the difficulties to develop NF-jB into novel drug targets for the treatment of chronic diseases, the cooperation with the IRF5 pathway may open a new avenue for therapeutic intervention. Targeting IRF5 might be appealing since a recent observation showed that the deficiency of IRF5 markedly suppressed the induction of proinflammatory cytokines yet did not interfere with NFjB signaling [3] . Even though there are quite a few treatment options for psoriasis the heterogeneity of the patient population leaves the need for new medications open. Additionally, since biologics are presently the most efficacious therapeutics, low molecular weight compounds with their cost and ease of administration are desirable. Currently licensed biologic therapies used for the treatment of moderate to severe psoriasis are antagonists neutralizing TNFa (infliximab, etanercept, and adalimumab), IL-17 (secukinumab), and IL-12/23 (ustekinumab) [43] . Etanercept has been shown to be highly efficacious in the treatment of psoriasis patients with severe symptoms [44] . Secukinumab is an effective and generally well tolerated first-line treatment for moderate to severe plaque psoriasis and is a useful addition to the treatment options for this disease [45] . Similarly, ustekinumab demonstrated stable clinical response with a good safety profile [46, 47] . However, all biologics so far showed quite heterogeneous responses in the clinic underlining the need for additional treatment options. Another advantage of drugs targeting IRF5 might be the impact on IL-1b secretion, a cytokine detected throughout the thickened psoriatic epidermis and some dermal areas in psoriatic lesions [48] . Zwicker et al. [49] described a signaling loop whereby increased IL-1b accelerates in turn the IL-17 levels which in response triggers the activation of the inflammasome and subsequently feeds back to increase the IL-1b production even further. Antagonists for inflammatory mediators involved in the development or function of TH17 lymphocytes and the newly approved biologics Guselkumab and Tildrakizumab specifically targeting IL-23 (by targeting the p19 subunit) provide additional treatment options for patients with severe psoriasis [43] .
Furthermore, the demonstrated importance of TLR signaling in psoriasis [50, 51] indicate that drugs interfering with the interactions of IRF5 and NF-jB might satisfy unmet medical needs for moderate to severe psoriasis. Inhibition of IRF5 activity or the interplay with certain members of the NF-jB family may therefore pave the way for the development of more selective drugs targeting the basic mechanisms underlying inflammatory immune responses.
While this study offers mechanistic insides into the cooperation of IRF5 and NF-jB, we are aware of the limitations based on the sole use of the THP-1 clones. Future studies will include the use of primary human macrophages derived from blood monocytes to validate the data. However we have already generated data that make us believe in the relevance of THP-1 clones as a model for human skin derived macrophages: primary human CD163 + macrophages isolated from skin of healthy volunteers express high levels of IRF5 and p65 mRNA similar to what is seen in THP-1 cells. Furthermore among the TLRs 7-9 whose aberrant activation are now recognized as an initiating event in the inflammatory cascade driving the pathogenesis of psoriasis [52] , highest expression is seen for TLR8 in skin derived human CD163 + macrophages and THP-1 cells (JCU Lehmann, unpublished data).
Materials and methods
Lentiviral generation of THP-1
DuCa transgenic cells 
Cell culture
The monocyte cell lines THP-1 (ATCC, Manassas, VA, USA), THP- 
siRNA knock down
For siRNA inhibition studies, the cells were transfected with human p65 siRNA pools (SI00301672 and SI02663094; Qiagen, Hilden, Germany) or negative control siRNA (SI03650318; Qiagen) at a final concentration of 300 pmol in the presence of P3 nucleofection solution with the pulse EA-100 in a 4D Nucleofector X unit (Lonza, Basel, Switzerland). Prior conducting further experiments the cells were rested for 48 h and protein KD was confirmed with WES capillary western blot.
WES capillary western blot
WES reagents including capillaries, sample plates, antibody diluent buffer, biotinylated molecular weight ladder, Streptavidin-HRP, DTT, fluorescent standards, luminol-S, peroxide, sample buffer and secondary anti-rabbit and antimouse HRP antibodies were provided by the WES Master Kit and the WES Separation Module (#PS-MK17 and #SM-W004, ProteinSimple, San Jose, CA, USA). Experiments were performed according to the manufactures instructions from Protein Simple. Briefly, cells were lysed in RIPA buffer (#89901, Thermo Fisher, Rheinach, Switzerland) supplemented with phosphatase and protease inhibitors (#11836153001, and #4906837001, Roche, distributed by Sigma-Aldrich, Buchs, Switzerland). Protein extracts were combined with the fluorescent master mix and loaded on the assay plate along with the primary antibodies (rabbit anti-human IRF5 (#21686, Abcam, Cambridge, UK), rabbit anti-human p65 (#8242, Cell Signaling, distributed via BioConcept, Allschwil, Switzerland), mouse anti-GAPDH (#ab8245, Abcam). 
Cytokine and chemokine detection
Statistics
Student's unpaired t-test was used to determine the statistical significance between means of experimental group and control. P ≤ 0.05 was considered statistically significant (*) and P ≤ 0.01 highly statistically significant (**).
